These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction. Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ. Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791 [Abstract] [Full Text] [Related]
3. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials. Lv Y, Zou Z, Chen GM, Jia HX, Zhong J, Fang WW. Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032 [Abstract] [Full Text] [Related]
12. Blood pressure reduction and cardiovascular prevention: an update including the 2003-2004 secondary prevention trials. Staessen JA, Li Y, Thijs L, Wang JG. Hypertens Res; 2005 May; 28(5):385-407. PubMed ID: 16156503 [Abstract] [Full Text] [Related]
13. Do ancillary properties of antihypertensive drugs explain the outcome results of recent trials? Staessen JA, Wang J. J Nephrol; 2002 May; 15(4):422-7. PubMed ID: 12243374 [Abstract] [Full Text] [Related]
14. Does combination therapy with a calcium channel blocker and an ACE inhibitor have additive effects on blood pressure reduction? Edelman DA, Paul RA. Int J Clin Pract; 2000 Mar; 54(2):105-9. PubMed ID: 10824365 [Abstract] [Full Text] [Related]
15. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. Law MR, Morris JK, Wald NJ. BMJ; 2009 May 19; 338():b1665. PubMed ID: 19454737 [Abstract] [Full Text] [Related]
17. Blood pressure and metabolic effect of a combination of lercanidipine with different antihypertensive drugs in clinical practice. Cicero AF, Gerocarni B, Rosticci M, Borghi C. Clin Exp Hypertens; 2012 May 19; 34(2):113-7. PubMed ID: 21967031 [Abstract] [Full Text] [Related]
18. Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: an 8-week uncontrolled trial. Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L. Am J Kidney Dis; 2007 Dec 19; 50(6):908-17. PubMed ID: 18037091 [Abstract] [Full Text] [Related]
20. [The combination of an ACE inhibitor and a calcium channel blocker is an optimal combination for the treatment of hypertension]. Widimský J. Vnitr Lek; 2009 Feb 19; 55(2):123-30. PubMed ID: 19348394 [Abstract] [Full Text] [Related] Page: [Next] [New Search]